Spero Therapeutics, Inc. (SPRO)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $63k
- May 4 · No plan
- Form 4 sales
- 49
- On record
- Form 144 notices
- 2
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planAug 28 2025
Sold 1,695 shares at $1.97 ($3k)
Keutzer Timothy, Chief Operating Officer
No 10b5-1 planSold 0.2% of holdings ($1.5M position)739,744 shares left0.1x usual sizeFiling
- 2 Form 4 saleNo planAug 28 same day
Sold 6,572 shares at $1.97 ($13k)
Mahadevia Ankit, Director
No 10b5-1 planSold 0.9% of holdings ($1.4M position)703,294 shares left0.1x usual sizeFiling
- 3 Form 4 saleNo planNov 7 +71 days
Sold 40,270 shares at $2.37 ($95k)
Rajavelu Esther, Officer
No 10b5-1 planSold 4.4% of holdings ($2.2M position)869,450 shares leftFiling
- 4 Form 4 saleNo planFeb 2 +87 days
Sold 18,442 shares at $2.20 ($41k)
Rajavelu Esther, Officer
No 10b5-1 planSold 1.6% of holdings ($2.5M position)1.1M shares left0.5x usual sizeFiling
- 5 Form 4 saleUnusualFeb 4 +2 days
Sold 46,586 shares at $2.17 ($101k)
Keutzer Timothy, Chief Operating Officer
No 10b5-1 planSold 5.8% of holdings ($1.8M position)761,158 shares left21.1x usual sizeFiling
- 6 Form 4 saleNo planFeb 6 +2 days
Sold 18,652 shares at $2.36 ($44k)
Keutzer Timothy, Chief Operating Officer
No 10b5-1 planSold 2.5% of holdings ($1.8M position)742,506 shares left0.8x usual sizeFiling
- 7 Form 4 saleNo planFeb 6 same day
Sold 87,917 shares at $2.36 ($207k)
Rajavelu Esther, Officer
No 10b5-1 planSold 8% of holdings ($2.6M position)1M shares left2.9x usual sizeFiling
- 8 Form 4 saleNo planMay 4 +87 days
Sold 25,240 shares at $2.51 ($63k)
Rajavelu Esther, Officer
No 10b5-1 planSold 2.5% of holdings ($2.5M position)986,851 shares left0.6x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (51)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Rajavelu Esther | Officer | Form 4 sale | 25,240 | $63k | 2.5% | No plan | SEC |
| Feb 6, 2026 | Rajavelu Esther | Officer | Form 4 sale | 87,917 | $207k | 8.0% | No plan | SEC |
| Feb 6, 2026 | Keutzer Timothy | Chief Operating Officer | Form 4 sale | 18,652 | $44k | 2.5% | No plan | SEC |
| Feb 4, 2026 | Keutzer Timothy | Chief Operating Officer | Form 4 sale | 46,586 | $101k | 5.8% | Unusual | SEC |
| Feb 2, 2026 | Rajavelu Esther | Officer | Form 4 sale | 18,442 | $41k | 1.6% | No plan | SEC |
| Nov 7, 2025 | Rajavelu Esther | Officer | Form 4 sale | 40,270 | $95k | 4.4% | No plan | SEC |
| Aug 28, 2025 | Mahadevia Ankit | Director | Form 4 sale | 6,572 | $13k | 0.9% | No plan | SEC |
| Aug 28, 2025 | Keutzer Timothy | Chief Operating Officer | Form 4 sale | 1,695 | $3k | 0.2% | No plan | SEC |
| Feb 5, 2025 | Keutzer Timothy | Chief Operating Officer | Form 4 sale | 56,537 | $44k | 7.1% | Unusual | SEC |
| Feb 5, 2025 | Rajavelu Esther | CFO & CBO | Form 4 sale | 20,689 | $16k | 2.8% | No plan | SEC |
| Feb 5, 2025 | Shukla Sath | CEO & President | Form 4 sale | 155,333 | $121k | 8.2% | Unusual | SEC |
| Feb 5, 2025 | Mahadevia Ankit | Director | Form 4 sale | 69,219 | $54k | 9.1% | Unusual | SEC |
| Nov 8, 2024 | Rajavelu Esther | CFO & CBO | Form 4 sale | 40,596 | $53k | 9.7% | No plan | SEC |
| Aug 27, 2024 | Mahadevia Ankit | Director | Form 4 sale | 5,912 | $8k | 0.8% | No plan | SEC |
| Aug 27, 2024 | Keutzer Timothy | Chief Operating Officer | Form 4 sale | 2,213 | $3k | 0.4% | No plan | SEC |
| Aug 27, 2024 | Shukla Sath | CEO & President | Form 4 sale | 2,757 | $4k | 0.2% | No plan | SEC |
| Aug 5, 2024 | Shukla Sath | CEO and President | Form 4 sale | 32,441 | $43k | 2.8% | Unusual | SEC |
| Feb 5, 2024 | Shukla Sath | Officer, Director | Form 144 notice | 45,093 | $65k | Notice | SEC | |
| Feb 5, 2024 | Shukla Sath | CEO and President | Form 4 sale | 75,994 | $108k | 6.1% | Unusual | SEC |
| Feb 2, 2024 | Keutzer Timothy | Chief Operating Officer | Form 4 sale | 30,971 | $42k | 5.5% | No plan | SEC |
| Feb 2, 2024 | Mahadevia Ankit | Director | Form 4 sale | 63,795 | $87k | 7.9% | No plan | SEC |
| Feb 2, 2024 | Joseph Tamara L | Chief Legal Officer | Form 4 sale | 30,906 | $42k | 5.5% | No plan | SEC |
| Feb 2, 2024 | Hamed Kamal | Chief Medical Officer | Form 4 sale | 28,075 | $38k | 3.4% | No plan | SEC |
| Sep 13, 2023 | Hamed Kamal | Chief Medical Officer | Form 4 sale | 39,496 | $50k | 6.4% | No plan | SEC |
| Aug 29, 2023 | Shukla Sath | CEO and President | Form 4 sale | 6,017 | $8k | 1.0% | Routine | SEC |
| Aug 29, 2023 | Shukla Sath | Officer | Form 144 notice | 4,163 | $5k | Notice | SEC | |
| Aug 28, 2023 | Keutzer Timothy | Chief Development Officer | Form 4 sale | 1,854 | $2k | 0.6% | No plan | SEC |
| Aug 28, 2023 | Joseph Tamara L | Chief Legal Officer | Form 4 sale | 1,854 | $2k | 0.6% | No plan | SEC |
| Aug 28, 2023 | Mahadevia Ankit | Director | Form 4 sale | 9,040 | $11k | 1.1% | No plan | SEC |
| Feb 3, 2023 | Mahadevia Ankit | CEO and President | Form 4 sale | 12,286 | $22k | 1.5% | Plan not stated | SEC |
| Feb 2, 2023 | Keutzer Timothy | Chief Operating Officer | Form 4 sale | 3,394 | $6k | 1.0% | Plan not stated | SEC |
| Feb 2, 2023 | Joseph Tamara L | Chief Legal Officer | Form 4 sale | 3,394 | $6k | 1.0% | Plan not stated | SEC |
| Feb 2, 2023 | Shukla Sath | Chief Financial Officer | Form 4 sale | 9,504 | $17k | 3.0% | Plan not stated | SEC |
| Sep 22, 2022 | Aquilo Capital Management, LLC | 10% owner | Form 4 sale | 1.9M | $4.3M | 35.7% | Unusual | SEC |
| Aug 29, 2022 | Shukla Sath | Chief Financial Officer | Form 4 sale | 6,017 | $5k | 9.7% | Plan not stated | SEC |
| Dec 27, 2021 | Mahadevia Ankit | CEO and President | Form 4 sale | 8,000 | $117k | 5.3% | Plan not stated | SEC |
| Feb 8, 2021 | Aquilo Capital Management, LLC | 10% owner | Form 4 sale | 3,000 | $65k | 0.1% | Plan not stated | SEC |
| Feb 4, 2021 | Aquilo Capital, L.P. | 10% owner | Form 4 sale | 100,000 | $1.9M | 2.5% | Plan not stated | SEC |
| Dec 17, 2020 | Aquilo Capital, L.P. | 10% owner | Form 4 sale | 264,933 | $5M | 6.3% | Plan not stated | SEC |
| Dec 16, 2020 | Larkin Cristina | Chief Operating Officer | Form 4 sale | 12,000 | $228k | 88.9% | Unusual | SEC |
| Nov 9, 2020 | Aquilo Capital, L.P. | 10% owner | Form 4 sale | 125,900 | $1.7M | 2.9% | Plan not stated | SEC |
| Nov 6, 2020 | Aquilo Capital, L.P. | 10% owner | Form 4 sale | 174,100 | $2.5M | 3.9% | Plan not stated | SEC |
| Nov 4, 2020 | Mahadevia Ankit | CEO and President | Form 4 sale | 9,507 | $137k | 12.6% | Unusual | SEC |
| Oct 23, 2020 | Mahadevia Ankit | CEO and President | Form 4 sale | 20 | $285 | 0.0% | Plan not stated | SEC |
| Oct 14, 2020 | Mahadevia Ankit | CEO and President | Form 4 sale | 14,472 | $207k | 18.0% | Unusual | SEC |
| Sep 8, 2020 | Mahadevia Ankit | CEO and President | Form 4 sale | 774 | $11k | 1.2% | Plan not stated | SEC |
| Jul 9, 2020 | Mahadevia Ankit | CEO and President | Form 4 sale | 3,047 | $44k | 4.4% | Plan not stated | SEC |
| Jun 25, 2020 | Mahadevia Ankit | CEO and President | Form 4 sale | 17,180 | $246k | 20.7% | Plan not stated | SEC |
| Jul 6, 2018 | Mahadevia Ankit | Officer, Director | Form 4 sale | 4,676 | $82k | 6.6% | Plan not stated | SEC |
| Jul 5, 2018 | Larkin Cristina | Chief Operating Officer | Form 4 sale | 4,000 | $70k | 72.7% | Unusual | SEC |
| Jul 5, 2018 | Sendek Joel | Chief Financial Officer | Form 4 sale | 2,000 | $35k | 11.6% | Plan not stated | SEC |